Paul Goldberg - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Paul Goldberg's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists todayPaul Goldberg
Verified
Editor and Publisher, The Cancer Letter
Washington
Beats
local news breaking news
Content
By Paul Goldberg Verified| The Cancer Letter Verified Sometimes in oncology, you get “beat-the-reaper” stories. To access this subscriber-only content please log in or renew your subscription. Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
By Paul Goldberg Verified| The Cancer Letter Verified As over 40,000 oncology professionals descend on Chicago’s McCormick Place yet again for the 60th American Society of Clinical Oncology annual meeting, we invite you to look back at The Cancer Letter and the Cancer History Project’s past coverage of the event.
By Paul Goldberg Verified| The Cancer Letter Verified As over 40,000 oncology professionals descend on Chicago’s McCormick Place yet again for the 60th American Society of Clinical Oncology annual meeting, we invite you to look back at The Cancer Letter and the Cancer History Project’s past coverage of the event.
Company Info
The Cancer Letter
The Cancer Letter is an independent weekly news publication that focuses on cancer research, drug development, healthcare policy, and legislative issues in oncology. Founded in 1973 by journalist Jerry D. Boyd, it has established itself as a leading authority in oncology journalism, known for its investigative reporting and editorial independence. The publication transitioned to a fully digital format in 2008 and is based in Washington, D.C. The Cancer Letter offers a core publication that includes weekly issues covering various aspects of oncology. It features the Clinical Cancer Letter, which provides clinicians with trial data, treatment guidelines, and practice updates. The publication also includes guest editorials that highlight community perspectives, particularly during significant events like the COVID-19 pandemic. With over 200 institutional subscribers, including academic medical centers and research institutions, it serves approximately 40,000 professionals in the oncology field.
Washington, District of Columbia, United States
+1 202-362-1809
Founded: 1973